Back to search

Article

Perm1 Gene Therapy Mitigates PRDM16-Associated Cardiomyopathy

2026-04-15

Abstract excerpt

<h4>Background</h4> Pathogenic variants in PR domain containing 16 ( PRDM16 ) cause pediatric and adult cardiomyopathies characterized by ventricular dilation, systolic dysfunction, and impaired metabolic maturation. Cardiac deficiency of PRDM16 alters metabolic gene expression and long-chain fatty acid (FA) metabolites. However, the downstream mediators involved are not well characterized. Furthermore, whether...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
43de17a5-8fb6-5ee8-b582-97acb1cfc94c
DOI
10.64898/2026.04.13.718330
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Perm1 Gene Therapy Mitigates PRDM16-Associated CardiomyopathyDOI 10.64898/2026.04.13.718330
Select a neighboring publication to make it the new centre.